Print Page  Close Window

SEC Filings

8-K
VITAE PHARMACEUTICALS, INC filed this Form 8-K on 10/25/2016
Entire Document
 

 

VITAE PHARMACEUTICALS, INC.

 

AMENDED AND RESTATED BYLAWS

 

Table of Contents

 

 

Page

 

 

ARTICLE I MEETINGS OF STOCKHOLDERS

1

 

 

Section 1.01. Annual Meetings

1

Section 1.02. Special Meetings

1

Section 1.03. Participation in Meetings by Remote Communication

1

Section 1.04. Notice of Meetings; Waiver of Notice

1

Section 1.05. Proxies

2

Section 1.06. Voting Lists

2

Section 1.07. Quorum

3

Section 1.08. Voting

3

Section 1.09. Adjournment

3

Section 1.10. Organization; Procedure

3

Section 1.11. Consent of Stockholders in Lieu of Meeting

4

 

 

ARTICLE II BOARD OF DIRECTORS

4

 

 

Section 2.01. General Powers

4

Section 2.02. Number and Term of Office

5

Section 2.03. Election of Directors

5

Section 2.04. Regular Meetings

5

Section 2.05. Special Meetings

5

Section 2.06. Notice of Meetings; Waiver of Notice

5

Section 2.07. Quorum; Voting

6

Section 2.08. Action by Telephonic Communications

6

Section 2.09. Adjournment

6

Section 2.10. Action Without a Meeting

6

Section 2.11. Regulations

6

Section 2.12. Resignations of Directors

6

Section 2.13. Removal of Directors

6

Section 2.14. Vacancies and Newly Created Directorships

7

Section 2.15. Compensation

7

Section 2.16. Reliance on Accounts and Reports, etc.

7

 

 

ARTICLE III COMMITTEES

7

 

 

Section 3.01. Designation of Committees

7

Section 3.02. Members and Alternate Members

7

Section 3.03. Committee Procedures

8

Section 3.04. Meetings and Actions of Committees

8

Section 3.05. Resignations and Removals

8